| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06411821 | Ulixertinib in People With Histiocytic Neoplasms | Histiocytic Neoplasms | Recruiting |
| NCT06400225 | Testing BVD-523FB (Ulixertinib) as Potentially Targeted Treatment in Cancers With Genetic… | Advanced Lymphoma | Active, Not Recruiting |
| NCT03698994 | Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or… | Advanced Malignant Solid Neoplasm | Active, Not Recruiting |
| NCT03155620 | Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed… | Advanced Malignant Solid Neoplasm | Active, Not Recruiting |
| NCT02465060 | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced… | Advanced Lymphoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06773195 | A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis | Myelofibrosis | Recruiting |
| Phase 1 | |||
| NCT05985954 | Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With… | Metastatic Colorectal Cancer | Recruiting |
| Early Phase 1 | |||
| NCT05804227 | Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas | Gliomas | Recruiting |